Cargando…
Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases
BACKGROUND: The pathological tumor burden score (TBS) has been proven to be a better risk stratification tool for liver metastasis of colorectal cancer than the traditional clinical risk score (CRS). The aim of this study was to evaluate the prognostic value of the pathological tumor burden score in...
Autores principales: | Liao, Leen, Sun, Hui, He, Jiahua, Liu, Yujun, Pan, Zhizhong, Wu, Xiaojun, Fan, Wenhua, Peng, Jianhong, Li, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492270/ https://www.ncbi.nlm.nih.gov/pubmed/37689651 http://dx.doi.org/10.1186/s12893-023-02145-w |
Ejemplares similares
-
Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy
por: Peng, Jianhong, et al.
Publicado: (2021) -
Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer
por: Peng, Jianhong, et al.
Publicado: (2021) -
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases
por: Wimmer, Kerstin, et al.
Publicado: (2016) -
Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007) -
Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
por: Ayez, Ninos, et al.
Publicado: (2011)